LC
ELV icon

Leon Cooperman’s Elevance Health ELV Stock Holding History

Leon Cooperman’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-227,900
Closed -$66.7M – 41
2026
Q1 		$66.7M Sell
227,900
-113,000
-33% -$37.1M 2.19% 16
2025
Q4 		$120M Hold
340,900
– – 3.96% 8
2025
Q3 		$110M Buy
340,900
+60,000
+21% +$18.7M 3.44% 8
2025
Q2 		$109M Buy
280,900
+2,500
+0.9% +$1.01M 3.84% 7
2025
Q1 		$121M Hold
278,400
– – 4.81% 5
2024
Q4 		$103M Buy
278,400
+107,400
+63% +$44.9M 3.89% 10
2024
Q3 		$88.9M Buy
171,000
+41,000
+32% +$21.9M 3.78% 10
2024
Q2 		$70.4M Hold
130,000
– – 2.97% 14
2024
Q1 		$67.4M Hold
130,000
– – 2.81% 16
2023
Q4 		$61.3M Buy
130,000
+11,860
+10% +$5.48M 2.92% 15
2023
Q3 		$51.4M Buy
118,140
+58,140
+97% +$26.4M 2.69% 15
2023
Q2 		$26.7M Buy
+60,000
New +$27.7M 1.45% 22

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Leon Cooperman's ELV Position: Q2 2026 in Review

Leon Cooperman sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 227,900 shares — an estimated $66.7M sold.

Leon Cooperman first reported a position in ELV in Q2 2023 and held it in 12 quarters. The position peaked at $121M in Q1 2025. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Leon Cooperman reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Leon Cooperman sold 227,900 Elevance Health shares in Q2 2026, an estimated $66.7M.
  • Leon Cooperman first reported a position in Elevance Health in Q2 2023 and held it in 12 quarters.
  • Leon Cooperman's Elevance Health position peaked at $121M in Q1 2025.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cooperman Leon G's 13F filing for Q2 2026, filed 14 Aug 2026.